# A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti–Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-phase-ii-randomized-double-masked-trial-of-pegaptanib-an-anti-vascular/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Emmett T. Cunningham,Anthony P. Adamis,Michael M. Altaweel,Lloyd Paul Aiello,Neil M. Bressler,Donald J. D’Amico,Mauro Goldbaum,David R. Guyer,Barrett Katz,Manju Patel,Steven D. Schwartz |
| Citations | 594 |
| DOI | 10.1016/j.ophtha.2005.06.007 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1526282761 |
| PMID | 16154196 |
| Type | article |
| Year | 2005 |

## Paper authors

- [Steven D. Schwartz](https://scholariq.org/researchers/steven-d-schwartz/)

## Paper journal

- [Ophthalmology](https://scholariq.org/journals/ophthalmology/)

## Paper primary topic

- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)

## Paper topics

- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Retinal Development and Disorders](https://scholariq.org/topics/retinal-development-and-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.